SCHEMBL3712873

SCHEMBL3712873

CC(C)(C)OC(=O)N1CCCC(NC(=O)CCCBr)C1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 4/20 0.50
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
EPHX1 P07099 1/20 0.48
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
FPR3 P25089 1/20 0.46
FPR2 P25090 1/20 0.46
GLS O94925 2/20 0.45
HDAC4 P56524 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
PARP1 P09874 1/20 0.43
ANO1 Q5XXA6 2/20 0.43
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PBK Q96KB5 1/20 0.41
AHCY P23526 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24710621 1.00 USP30 (0.50) USP30CA1CA2EPHX1MEN1
SCHEMBL9932831 0.98 USP30 (0.51) USP30CA1CA2EPHX1MEN1
SCHEMBL1440247 0.98 USP30 (0.51) USP30CA1CA2EPHX1MEN1
SCHEMBL24711128 0.96 USP30 (0.50) USP30CA1CA2EPHX1MEN1
SCHEMBL24710447 0.96 USP30 (0.50) USP30CA1CA2EPHX1MEN1
SCHEMBL30919894 0.90 USP30 (0.50) USP30CA1CA2EPHX1MEN1
SCHEMBL13636131 0.84 USP30 (0.53) USP30CA1CA2EPHX1MEN1
SCHEMBL19408900 0.84 USP30 (0.53) USP30CA1CA2EPHX1MEN1
SCHEMBL13636132 0.84 USP30 (0.55) USP30CA1CA2EPHX1MEN1
SCHEMBL18959262 0.84 USP30 (0.53) USP30CA1CA2EPHX1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117480162-A Compounds for the treatment or prophylaxis of PRMT5 mediated diseases 阿古诺治疗有限公司 2024-01-30 CN disclosed
WO-2022258986-A1 COMPOUNDS USEFUL IN THE TREATMENT OR PREVENTION OF A PRMT5-MEDIATED DISORDER Argonaut Therapeutics Limited (GB) 2022-12-15 WO disclosed
WO-2010091721-A1 3 -SUBSTITUTED 1-ARYLSULFONYLPIPERIDINE DERIVATIVES FOR THE TREATMENT OF PAIN GLAXO GROUP LIMITED (GB) 2010-08-19 WO disclosed
WO-2010091721-A1 3 -SUBSTITUTED 1-ARYLSULFONYLPIPERIDINE DERIVATIVES FOR THE TREATMENT OF PAIN GLAXO GROUP LIMITED (GB) 2010-08-19 WO disclosed